TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ROIV

Roivant Sciences Ltd

Healthcare · Biotechnology

39.80$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ROIV
Line item 2019 2020 2021 2022 2023 2024 2025 2026
+0.0% +0.0% +217.9% +16.9% -36.1% -76.2%
+108.2% -30.7% +565.0% -61.5% -8.3% +44.8% +19.8%
+50.9% +24.1%
-69.2% +370.3% -78.1% -59.6% +200.0% -504.8%
-56.9% +18.1% +200.3% -27.2% -89.1% +232.8% +78.5%
-101.9% -114.6% -133.9% -61.4%
-96.3%
+16,014.8% -100.0% +200.9% -136,086.5% -75.3%
-70.6% -71.4% +0.0% +776.1% -123.7% +71.8% -100.0%
-71.7% +110.1% -32.8% +62.8% -16.0% -390.9%
+19.4% -109.5% -178.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?